Blog

T cells

Building CGT’s Clinical Trial Potential: PRA’s Partnership with Cell and Gene Therapy Supply Chain Software Leader Vineti

Key Highlights: PRA’s partnership with Vineti will optimize clinical trial delivery, clinical study operations and data management, and commercialization readiness…

Read More
November 23, 2020

How digital solutions solve the “3D chess game” and drive Commercial success

A Vineti technology perspective from Chief Commercial Officer Joe DePinto Joe DePinto, Vineti’s Chief Commercial Officer, is a long-time leader...

November 17, 2020

A modern patient ID for personalized medicine

Patient-specific therapeutics must be delivered to the patient they are intended to treat. That concept is easy to say —...

November 17, 2020

Now is the time for proven technology that drives scale

A Vineti technology perspective from CEO and Co-founder Amy DuRoss   The underlying medical science behind cell and gene therapies continues...

October 13, 2020

Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition

Today, we’re very excited and honored to announce the extension of our Series C round of funding. We’ve expanded the...

October 7, 2020

Vineti at Cell and Gene Meeting on the Mesa 2020

Next week marks the start of a very important annual event in advanced therapies — the Alliance for Regenerative Medicine’s...

October 7, 2020

Crispr’s Nobel Moment

“Crispr — overrated or underrated?” At this month’s CBInsights Future of Health conference, I had the good fortune to do a live...

August 25, 2020

OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies

Integrated Custom-Curated IO Clinical Trial Services and Personalized Therapy Management systems to seamlessly manage advanced therapy clinical journeys for cancer...

August 17, 2020

Vineti Announces New Chief Commercial Officer

Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene...

August 17, 2020

Q&A: five questions for Joe DePinto

Today, Vineti is thrilled to announce that Joe DePinto has joined us as our Chief Commercial Officer. Joe is a long-time leader in...

August 13, 2020

Vineti Inc. named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups

Vineti Inc. named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health StartupsVineti Inc....

August 11, 2020

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing health disorders with no cure

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions NEWARK, Del. and SAN...

July 29, 2020

Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO,...